TradingView’s own chart and price feed. The page’s numbers are end-of-day closes.
Data provided by Databento (end of day). Next close = the first close after a story against the close before it; official daily closes only, not a call, not advice.
The numbers
fiscal 2025, as filed with the SEC · 66-metric EOD snapshot via Databento
Market cap$119.2B
EV / True FCF12.7x
Revenue$48.2B −0.2%
True FCF (ex-SBC)$12.3B −7.9%
Rule of 4026.5%
True FCF Yield10.3%
EPS, diluted$3.46 +178.5%
Modern Valuation (EOD)
Market Cap$119.2B
Enterprise Value$156.0B
EV / True FCF12.69
EV / FCF12.15
EV / Gross Profit—
EV / EBIT—
EV / Sales3.24
P / E (GAAP)16.89
P / FCF9.28
P / Oper. CF8.42
P / Book6.44
Owner & Cash Yields
True FCF Yield10.3%
FCF Yield10.8%
Owner Earn. Yield7.7%
Earnings Yield5.9%
Shareholder Yield+3.8%
Buyback Yield0.0%
Dividend Yield4.23%
Dividend / sh$2.49
Payout Ratio72%
FCF / sh$6.28
EPS (diluted)$3.46
Compounder & Returns
Rule of 4026.5%
ROIC—
Cash ROIC (CROIC)23.2%
GP / Assets—
ROE38.1%
ROA7.8%
Gross Margin—
Oper. Margin—
Net Margin14.6%
FCF Margin26.7%
True FCF Margin25.5%
Quality & Dilution
Cash Conversion182%
Accrual Ratio−7.9%
SBC % of FCF4.3%
SBC % of Rev1.1%
Reinvest. Rate80%
Sales Growth Y/Y−0.2%
Sales 3Y CAGR+1.4%
EPS Growth Y/Y+178.5%
FCF Growth Y/Y−7.9%
FCF 3Y CAGR+2.4%
Share Change Y/Y+0.6%
Balance Sheet & Scale
Revenue (FY)$48.2B
Gross Profit (FY)—
Oper. Income (FY)—
GAAP Net Income$7.1B
True FCF (ex-SBC)$12.3B
Cash & Equiv$10.2B
Total Debt$47.1B
Net Cash (Debt)$-36.9B
Net Cash % MCap−30.9%
Debt / FCF (yrs)3.7y
Current Ratio1.262.04B sh
Price & Technicals (EOD)
Perf Week−7.30%
Perf Month−6.67%
Perf Quarter−12.60%
Perf Half Y−1.11%
Perf YTD+3.25%
SMA 20 Dist−4.88%$61.82
SMA 50 Dist−4.32%$61.45
SMA 100 Dist−5.83%$62.44
Window High−13.64%$68.09
Window Low+8.89%$54.00
RSI (14) · Vol39.428%v
Income Distribution & Cash Flow ConversionHow every dollar of BMY revenue flows through cost of goods, operating expenses, taxes, GAAP net income, and dilution-adjusted free cash flow
Unlocked SEC EDGAR Accounting Statements (USD)All 3 statements · Common-size (% of Revenue / Assets) · YoY growth · Tap any core row to explain
Line Item (USD)
FY2021
FY2022
FY2023
FY2024
FY2025
YoY Δ
4Y CAGR
Trend
Income Statement
Revenue ▸
$46.4B
$46.2B
$45.0B
$48.3B
$48.2B
−0.2%
+1.0%
Cost of Revenue (COGS)
$9.9B
$10.1B
$10.7B
$14.0B
$13.9B
−0.2%
+8.8%
Research & Development (R&D)
$10.2B
$9.5B
$9.3B
$11.2B
$10.0B
−10.8%
−0.6%
Selling, General & Admin (SG&A)
$7.7B
$7.8B
$7.8B
$8.4B
$7.3B
−13.6%
−1.4%
Interest Expense
$1.3B
$1.2B
$1.2B
$1.9B
$1.9B
−2.9%
+9.1%
Income Tax Expense
$1.1B
$1.4B
$400.0M
$554.0M
$2.3B
+310.1%
+20.3%
GAAP Net Income ▸
$7.0B
$6.3B
$8.0B
$-8.9B
$7.1B
+178.8%
+0.2%
Diluted EPS ▸
$3.12
$2.95
$3.86
$-4.41
$3.46
+178.5%
+2.6%
Diluted Shares
2.25B
2.15B
2.08B
2.03B
2.04B
+0.6%
−2.4%
Balance Sheet
Cash & Equivalents
$14.3B
$9.3B
$11.5B
$10.3B
$10.2B
−1.2%
−8.1%
Inventory
$2.1B
$2.3B
$2.7B
$2.6B
$2.7B
+5.2%
+6.4%
Total Current Assets
$33.3B
$27.3B
$31.8B
$29.8B
$29.4B
−1.3%
−3.0%
Total Assets
$109.3B
$96.8B
$95.2B
$92.6B
$90.0B
−2.8%
−4.7%
Total Current Liabilities
$21.9B
$21.9B
$22.3B
$23.8B
$23.4B
−1.5%
+1.7%
Total Debt (Short + Long Term)
$49.3B
$43.2B
$42.6B
$51.5B
$47.1B
−8.5%
−1.1%
Total Liabilities
$73.3B
$65.7B
$65.7B
$76.2B
$71.5B
−6.1%
−0.6%
Stockholders' Equity
$36.0B
$31.1B
$29.5B
$16.4B
$18.5B
+12.9%
−15.3%
Net Cash / (Net Debt)
$-35.0B
$-33.9B
$-31.1B
$-41.1B
$-36.9B
+10.4%
—
Invested Capital
$71.0B
$65.0B
$60.6B
$57.5B
$55.4B
−3.7%
−6.0%
Cash Flow & Capital Allocation
Operating Cash Flow (OCF) ▸
$16.2B
$13.1B
$13.9B
$15.2B
$14.2B
−6.8%
−3.3%
Depreciation & Amortization (D&A)
$10.7B
$10.3B
$9.8B
$9.6B
$4.0B
−58.2%
−21.7%
Stock-Based Compensation (SBC)
$583.0M
$457.0M
$518.0M
$507.0M
$553.0M
+9.1%
−1.3%
Capital Expenditures (CapEx)
$973.0M
$1.1B
$1.2B
$1.2B
$1.3B
+5.0%
+7.7%
Free Cash Flow (FCF) ▸
$15.2B
$11.9B
$12.7B
$13.9B
$12.8B
−7.9%
−4.2%
True FCF (ex-SBC Owner Cash)
$14.7B
$11.5B
$12.1B
$13.4B
$12.3B
−8.5%
−4.3%
Share Repurchases (Buybacks)
$6.3B
$8.0B
$5.2B
$0
$0
—
—
Dividends Paid
$4.4B
$4.6B
$4.7B
$4.9B
$5.0B
+3.7%
+3.5%
Fundamentals, income distribution and multi-year statements from SEC EDGAR filings (public domain). Valuation multiples, performance and technicals computed from Databento 1D EOD closes. For information only, not investment advice.
The Wire at 7 AM ET, free. Top stories with a bull and a bear case on each, every morning. No account needed.
What happened · big days
21 big days in a year, and what we hold on each
A big day is a close more than 3.08% from the one before, three times BMY’s median day (1.03%). On 9 of the 21, its peer group moved the same way at least half as far. We show what we hold. We never name a cause.
every other trading daya big day, numbered in the list below±3.08%Hover a bar for its day. Click a big day to open it.
Shaded: since our stories began, Jun 10. Tap a bar for its day.
#DayBMYWhat we hold that dayGroup (median of 4) · each
1 Nov 24, 2025+3.26%
Before our storiesgroup +1.0%, did not move with it
1Nov 24, 2025+3.26%
Before our stories
+1.0% did not move with itMRK +2.7 · JNJ +1.1 · LLY +1.0 · ABBV −2.9
2 Dec 3, 2025+5.62%
Before our storiesgroup +0.6%, did not move with it
2Dec 3, 2025+5.62%
Before our stories
+0.6% did not move with itABBV +2.6 · MRK +1.2 · JNJ −0.0 · LLY −1.2
3 Dec 15, 2025+3.59%
Before our storiesgroup +1.5%, did not move with it
3Dec 15, 2025+3.59%
Before our stories
+1.5% did not move with itLLY +3.4 · ABBV +1.9 · JNJ +1.2 · MRK −0.0
4 Jan 7, 2026+4.23%
Before our storiesgroup +2.7%, moved with BMY
4Jan 7, 2026+4.23%
Before our stories
+2.7% moved with BMYABBV +4.2 · LLY +4.1 · JNJ +1.3 · MRK −0.3
5 Feb 5, 2026+3.30%
Resultsgroup +1.0%, did not move with it
5Feb 5, 2026+3.30%
ResultsFirst close after the Feb 5 results filing
+1.0% did not move with itJNJ +1.4 · MRK +1.2 · ABBV +0.9 · LLY −7.8
6 Feb 6, 2026+4.15%
Before our storiesgroup +1.9%, did not move with it
6Feb 6, 2026+4.15%
Before our stories
+1.9% did not move with itLLY +3.7 · ABBV +2.0 · MRK +1.8 · JNJ +0.9
7 Apr 2, 2026−3.45%
Before our storiesgroup −1.2%, did not move with it
7Apr 2, 2026−3.45%
Before our stories
−1.2% did not move with itABBV −2.9 · LLY −2.0 · JNJ −0.4 · MRK +0.0
8 Apr 30, 2026+5.21%
Resultsgroup +2.4%, did not move with it
8Apr 30, 2026+5.21%
ResultsFirst close after the Apr 30 results filing
+2.4% did not move with itLLY +9.8 · ABBV +3.6 · JNJ +1.1 · MRK −1.6
9 May 1, 2026−3.91%
Before our storiesgroup +0.8%, did not move with it
9May 1, 2026−3.91%
Before our stories
+0.8% did not move with itABBV −2.2 · JNJ −1.2 · MRK +2.7 · LLY +3.1
10 Jun 1, 2026−3.90%
Before our storiesgroup −2.1%, moved with BMY
10Jun 1, 2026−3.90%
Before our stories
−2.1% moved with BMYMRK −3.0 · ABBV −2.2 · LLY −2.1 · JNJ −0.8
11 Jun 4, 2026+3.44%
Before our storiesgroup +4.0%, moved with BMY
11Jun 4, 2026+3.44%
Before our stories
+4.0% moved with BMYMRK +4.8 · LLY +4.3 · ABBV +3.6 · JNJ +2.2
12 Jun 26, 2026+3.85%
Nothing on BMYgroup +4.1%, moved with BMY
12Jun 26, 2026+3.85%
Nothing on BMYNo BMY story, brief or results filing in our record that day
+4.1% moved with BMYLLY +7.1 · ABBV +4.2 · JNJ +4.0 · MRK +2.6
13 Jul 14, 2026−4.03%
Nothing on BMYgroup −2.0%, did not move with it
13Jul 14, 2026−4.03%
Nothing on BMYNo BMY story, brief or results filing in our record that day
−2.0% did not move with itMRK −2.6 · LLY −2.5 · JNJ −1.5 · ABBV −1.3
14 Jul 15, 2026+3.11%
Nothing on BMYgroup +0.0%, did not move with it
14Jul 15, 2026+3.11%
Nothing on BMYNo BMY story, brief or results filing in our record that day
+0.0% did not move with itMRK +2.3 · LLY +0.3 · ABBV −0.3 · JNJ −2.7
15 Aug 5, 2026−3.43%
Nothing on BMYgroup +1.0%, did not move with it
15Aug 5, 2026−3.43%
Nothing on BMYNo BMY story, brief or results filing in our record that day
+1.0% did not move with itMRK +0.3 · ABBV +1.0 · JNJ +1.0 · LLY +4.9
16 Aug 20, 2026−3.17%
Nothing on BMYgroup −2.2%, moved with BMY
16Aug 20, 2026−3.17%
Nothing on BMYNo BMY story, brief or results filing in our record that day
−2.2% moved with BMYLLY −2.8 · JNJ −2.2 · MRK −2.1 · ABBV −1.6
17 Sep 8, 2026−3.19%
Nothing on BMYgroup −2.2%, moved with BMY
17Sep 8, 2026−3.19%
Nothing on BMYNo BMY story, brief or results filing in our record that day
−2.2% moved with BMYABBV −3.0 · JNJ −2.2 · LLY −2.2 · MRK −1.2
18 Oct 5, 2026−3.83%
Nothing on BMYgroup −0.6%, did not move with it
18Oct 5, 2026−3.83%
Nothing on BMYNo BMY story, brief or results filing in our record that day
−0.6% did not move with itMRK −3.3 · JNJ −1.2 · LLY +0.0 · ABBV +1.1
19 Oct 14, 2026+4.61%
Nothing on BMYgroup +3.5%, moved with BMY
19Oct 14, 2026+4.61%
Nothing on BMYNo BMY story, brief or results filing in our record that day
+3.5% moved with BMYMRK +3.8 · LLY +3.6 · ABBV +3.3 · JNJ +2.1
20 Oct 20, 2026+4.84%
Nothing on BMYgroup +2.8%, moved with BMY
20Oct 20, 2026+4.84%
Nothing on BMYNo BMY story, brief or results filing in our record that day
+2.8% moved with BMYLLY +3.5 · MRK +3.3 · ABBV +2.3 · JNJ +2.2
21 Nov 4, 2026+4.02%
Nothing on BMYgroup +3.5%, moved with BMY
21Nov 4, 2026+4.02%
Nothing on BMYNo BMY story, brief or results filing in our record that day
+3.5% moved with BMYMRK +3.9 · JNJ +3.8 · ABBV +3.1 · LLY +0.6
A story on the same day is not a cause, and a group move is not proof either. Group: the median of LLY, JNJ, ABBV and MRK that day, the largest companies in BMY’s SEC industry; “moved with BMY” means the same direction and at least half the size.
What’s next · results
Before the next report: what the first day after the last four did
Six trading days after each results filing (SEC 8-K, Item 2.02). BMY reports before the open, so day 1 is that day’s close. 3 of 4 times, day 6 ended on the same side as day 1.
Reported Feb 5, 2026
day 1+3.30%day 6+3.89%
Reported Apr 30, 2026
day 1+5.21%day 6−2.33%
Reported Jul 30, 2026
day 1+2.79%day 6+1.66%
Reported Oct 29, 2026
day 1+1.35%day 6+4.23%
Next report: expected late January to early FebruaryEstimated from the dates of its last four results filings. Not announced. Since the Oct 29 report: −2.92%. Four reports is a small sample.
Each line is BMY’s close against its close before the filing, on licensed end-of-day closes. What happened after each report, not a forecast; a move on the day is not a cause.
Same industry
BMY against four drug peers, a year at 100
BMY is up 27.1% in a year. Merck is up 36.8% and Johnson & Johnson 32.7%. Eli Lilly (+27.1%) matched it. Of these four, only AbbVie (+21.1%) did less. Weekly closes, Nov 21, 2025 = 100, on a log scale, so the same percentage move is the same height on every line.
End-of-day closes (Databento EOD), the last close of each week. The four peers are the largest US-listed companies by market value in BMY’s SEC industry (Pharmaceutical Preparations) with a year of closes. It shows what the closes did; a move here is not a cause, a forecast or a call.